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 Abstract 
In the 21st century, it is hard to reconcile the concepts of the western diet and overconsumption with 
the risk of micronutrient deficiencies. However, deficiencies can arise from poor dietary intake, 
alone or combined with physiological or metabolic injury. Micronutrients are essential to fulfil a 
broad range of biochemical and physiological functions, and are tightly regulated by homeostatic 
processes. Diagnosis of deficiency is complex and requires the use of separate investigations 
(dietary, functional, biochemical). While the role of micronutrients in the prevention or treatment of 
diseases (including cancer, type 2 diabetes) is of interest, a key driver for the vitamins and 
supplement market is their advertised potential to optimize health and performance in healthy 
individuals. The evidence so far indicates that multivitamins supplements offer no health protection, 
increase all-cause mortality, and risk of cancers in some subgroups. A nutritionally balanced diet is a 
safer way to achieve sufficiency.  
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 Micronutrients – intake, metabolism and storage 
There are 15 vitamins (11 water-soluble, and 4 lipid soluble) and 20 minerals (7 macroelements, 7 
trace elements) essential for sustaining human life (Table 1). All vitamins and minerals can be 
obtained from a balanced diet that includes the main food groups. That diseases can arise from 
dietary deficiency has been well understood since the identification, in the 18th century, that 
supplementing the diet with citrus fruit could cure scurvy.  
The physiological functions of micronutrients include acting as: 
 co-enzymes in key metabolic reactions; 
 antioxidants in the control of damage caused by reactive oxygen species; 
 modulators of gene transcription; 
 components of and co-factors for enzymes; and 
 structural components of tissues (1). 
 
The human body is highly adaptable with efficient homeostatic mechanisms, often under hormonal 
control, that balance the absorption, transport, storage, utilization and excretion of micronutrients. 
These mechanisms enable maintenance of appropriate circulating and stored reserves for use in 
tissue function. Such controls allow the body to function normally across a wide range of nutrient 
intakes, so that it can take some time before an overt deficiency disease materializes (Figure 1) (1).  
For example the metabolic pool of calcium in the extracellular fluid (ECF) is very small compared 
with the large skeletal reserves, mobilization of which compensates for an inadequate intake of 
calcium. Conversely, there are no specific reserves for minerals such as zinc and the water-soluble 
vitamins, and the body is largely dependent on a regular supply in the diet. Interestingly, there is no 
physiological mechanism for iron excretion and iron balance is maintained through the regulation of 
its absorption from the diet. If iron is not required, it is stored in duodenal mucosal cells as ferritin 
and excreted in the faeces when mucosal cells are exfoliated. 
The bioavailability of a nutrient can be defined as the proportion of that nutrient ingested from a 
particular food that can be absorbed and made available to the body for normal metabolic functions. 
This is the result of the interaction between the nutrient, other components of the diet (the food 
matrix) and the physiological status of the individual. For example, ascorbic acid (vitamin C) will 
increase non-haem iron absorption, as will the presence of haem iron in the duodenum and the iron 
deficient status of the individual. Conversely phytates, iron-binding phenolic compounds and replete 
iron stores will decrease absorption. Several vitamins and minerals, such as calcium, iron, zinc and a 
number of the B vitamins display such interactions. 
 
Phytochemicals 
Foods, especially plant foods, contain phytochemicals (including polyphenols, sterols), which are not 
recognized as nutrients but may have properties (e.g. antioxidant, anti-inflammatory or cholesterol-
lowering) that are health-promoting. These properties have fuelled the expansion of the nutritional 
supplement market, despite the European Food Safety Authority (EFSA) regulating the health claim 
market in Europe and requiring substantial evidence to justify claims (2).  
The UK’s Department of Health report on dietary reference values found no convincing evidence 
that it is necessary to include such compounds in a normal human diet and thus gave no further 
consideration to these or other unnecessary substances, including ornithine, orotic acid, lecithin, 
‘vitamin B15’ (pangamic acid), ‘vitamin B17’ (laetrile), bioflavonoids (e.g. rutin, hesperidin, quercitin) 
or ubiquinones (coenzyme Q) (3).  
 
Too much, too little – the U-shape relationship between micronutrients and health 
A U-shape describes the dose-response relationship of micronutrients, with insufficient intake 
increasing the risk of deficiency, and excessive intake (acute and chronic exposure) increasing the 
risk of toxicity and associated diseases.  
Countries worldwide, including the UK, have sought to publish dietary reference values (DRVs) (3). 
These recommendations are only an estimate at a population level, designed to be used as a 
yardstick for the assessment of dietary surveys and food statistics, for food labelling and to provide 
guidance on dietary composition.  
In the UK, DRVs are set at a level needed to maintain a circulating concentration and a degree of 
enzyme saturation or tissue concentration of a given nutrient, in addition to ensuring that there are 
no clinical signs of a deficiency disease. This is a highly complex challenge, relying on many 
assumptions, including a nutrient’s effects at different levels of intake, with individual requirements 
depending on age, gender and physiological state. DRVs are set on the assumption that individuals 
are in good health and not suffering from an existing deficiency. Where there is sufficient evidence, 
DRVs for micronutrients are set at a value believed the meet the needs of 97.5% of the population, 
known as the reference nutrient intake (RNI).  
RNI values vary by age and gender. Additional recommendations are made for pregnancy, lactation 
and in old age for Vitamin D only (3).  
(Figure 2) Different countries take a different approach to setting DRVs with their own terminology, 
creating confusion (e.g. RNI in UK, Recommended Daily allowance (RDA) in the USA and Population 
Reference Intake (PRI) in the EU) and resulting in inappropriate use of the recommendations. 
 
There is insufficient evidence to set DRVs for some micronutrients, for example pantothenic acid, 
biotin, Vitamin E, Vitamin K, manganese, molybdenum, chromium and fluoride. In these cases the 
UK panel set ‘safe intake’ levels – a level or range of intake at which there is no risk of deficiency, but 
below a level that may produce undesirable effects. 
 
Diagnosing deficiencies 
Diagnosing deficiencies requires the integration of clinical/functional data (e.g. night blindness for 
vitamin A, lipid peroxidation for vitamin E, mean corpuscular volume for iron), dietary data (reported 
intakes, taking into consideration the risk of under/over-reporting) and biochemical data (e.g. 
plasma retinol for vitamin A, urinary iodine excretion). Comparison of intake with population 
thresholds (especially lower reference nutrient intake (LRNI)) is a first indicator of potential 
deficiencies, and may guide subsequent investigations. However, poor absorption or excretion can 
trigger deficiency in the presence of adequate intake (e. g. B12 deficiency). Infection and stress may 
also impact on nutritional status.  
Biochemical analysis relies on collection of biological samples, most often plasma or serum, but also 
blood cells, urine, or hair. The impact of storage and handling on the stability of the analyte must be 
considered, and the analytical technique used should be specific, sensitive over the range of interest, 
robust, with normative data and quality controls available for interpretation and quality assurance 
(4, 5). 
 
Are we at risk? 
Overt deficiency diseases are relatively rare in industrialized countries, with the exception of iron 
deficiency and iron deficiency anaemia. Assessment of iodine status in UK schoolgirls indicated mild 
insufficiency at a population level, based on urinary iodine excretion (6).  
The National Diet and Nutrition Survey (NDNS) reported that, on average, intakes of the majority of 
vitamins were adequate, as indicated by dietary intakes and biochemical indices of nutritional status, 
with some key exceptions (7) (Table 2).These results are at a population level and rely heavily on 
self-reporting of dietary intake, a notoriously imprecise methodology, and the health implications of 
such nutritional surveillance reports remain unclear.  
 
Diet Quality 
 
There are several components of diet quality, often confused.  Terms such as ‘healthy’ have 
no definition, and are used only for marketing, often implying effect on body weight.  The 
term ‘nutritionally balanced’ refers to diets, or meals, which have nutrient compositions 
which approximate to the dietary needs for optimal health.  It is not useful to consider 
nutritional balance of individual foods or ingredients, which must be combined in different 
proportions to make up meals.  For foods, the concept of ‘nutrient density’ can be valuable 
in nutritional science, referring to the density of nutrients per unit energy (per 1000kcal).  
This must be distinguished from density per unit weight, as used in food science.  A high-
quality diet has other cultural and economic features, so might be based on meals built on 
(wide, seasonal, locally sourced, unprocessed etc) selections of nutrient-rich foods, to match 
the reference intakes for all nutrients but without exceeding the reference energy intake. 
 
Should we supplement? 
The use of micronutrient pills and other nutritional supplements is currently suggested in three 
situations: 
1. To correct deficiencies due to inadequate dietary intake (e.g. iron deficiency anaemia). 
2. In disease states where requirements are enhanced (e.g. critically ill patients) or absorption 
compromised (e.g. Crohn’s disease). 
3. To promote health and performance, and protect against future chronic diseases in healthy 
individuals. 
It is the last of these situations that is the most controversial and has the least clear evidence to 
support clinical decisions (8). Recommendations for supplementation in the healthy population are 
few, and includes, for example, folic acid before and during pregnancy and vitamin D in the young 
child. Despite the health claim market being tightly regulated by EFSA, and no recommendation 
being made, the use of vitamin pills and nutritional supplements generates almost US$50 billion 
globally (£751 million in 2013 in the UK) and is forecast to grow by 4% annually through to 2018 (9, 
10). 
Epidemiological studies, such as the EPIC prospective cohort study, have shown associations 
between vitamin supplementation and disease prevention (11). However, none of the randomized 
control trials reached the same positive conclusion, raising questions about the adequacy of dose 
setting and selected length of exposure  in the trials  with further concerns of systematic errors (12, 
13). One exception is vitamin D, which has been associated with decreased mortality in elderly 
institutionalised women (14). 
Meta-analyses of the available trials revealed that, beside there being no beneficial effect, some 
supplements could actually be harmful, with high doses of antioxidants such as -carotene, vitamin 
A, vitamin E and multivitamins linked positively to all-cause mortality, although this association has 
sometime been disputed (15, 16). In two trials (the beta-carotene and retinol efficacy trial - CARET 
and the Alpha-Tocopherol, Beta-Carotene Cancer Prevention Study - ATBC), high dose beta-carotene 
(20-30mg/day)  caused increased incidence of lung cancer and mortality in male smokers (17, 18). 
Several hypotheses exist as to why beta-carotene supplementation was harmful in these trials, with 
no clear consensus so far. Potential mechanisms involve the interaction of high dose beta-carotene 
with cigarette smoke, and impaired retinoic acid mediated signal transduction, pro-oxidant action of 
beta-carotene in the oxygen-rich lung environment, and cytochrome P450 induction, all potentially 
contributing to tumour formation (19).  
Besides being a potential waste of time and money for the healthy individual (20), supplementing 
with antioxidants to combat oxidative stress and ageing could also be an error if, as has been 
suggested, oxidative stress is a desirable feature (a low dose of the stimulus, oxidative stress, 
activating an adaptive response, ultimately to increase resistance to more severe stress) (21).  
 
While supplementation to address a diagnosed deficiency, or through a specific stage of the lifecycle 
with increased needs is justified, the modern drive to use vitamin pills and supplements to prevent 
future disease and improve an otherwise healthy status is not supported by evidence, and can be 
harmful for some.A nutritionally balanced diet provides all the essential vitamins and minerals and 
micronutrient levels in the body are tightly regulated by homeostatic processes.  
 
 
Figure 1 | From depletion through deficiency to clinical manifestations (22) 
 
 
  
Figure 2| COMA dietary reference values and nutrient requirements (3) 
 
(a) LRNI – level of nutrient intake that will meet the needs of approximately 2.5% of the population, 
habitual intake below LRNI will almost certainly be inadequate to meet individual needs. 
 Alternative terminology: EU - Lower Threshold Intake (LTI) USA - No equivalent 
(b) EAR – the estimated average requirement (mean) for a group for a particular nutrient  
Alternative terminology: EU - Average Requirement (AR) USA – Estimated Average Requirement (EAR) 
(c) RNI – level of nutrient intake which is sufficient for 97.5% of the population, exceeds the requirement 
for most people and habitual intakes above RNI are almost certain to be adequate 
Alternative terminology: EU – Population Reference Intake (PRI) USA – Recommended Daily 
Allowance (RDA) 
 
 
Table 1 | Summary of micronutrient physiological functions and deficiency diseases 
 Vitamins Physiological functions  Known deficiency diseases (a)  Possible benefits of high 
status(23, 24) 
A - Retinol, beta-
carotene 
Visual pigments, gene expression, cell differentiation, 
antioxidant 
 Night blindness, xerophthalmia, keratinization 
of the skin 
  
D - Calciferol Calcium homeostasis, cell maturation in small intestine, 
insulin secretion 
 Rickets (poor mineralization of bone), 
osteomalacia (demineralization of bone) 
  Some cancers, diabetes, 
metabolic syndrome, 
multiple sclerosis 
E - Tocopherols Antioxidant, particularly in cell membranes  Rare - serious neurological dysfunction   Atherosclerosis and 
ischemic heart disease 
K – Phylloquinone, 
Menaquinones 
Coenzyme for enzymes of blood clotting and bone matrix  Impaired blood clotting, haemorrhagic disease   
C - Ascorbic acid Antioxidant, promotes iron absorption, collagen synthesis, 
production of noradrenaline, inhibits production of 
nitrosamines in stomach 
 Scurvy (impaired wound healing, loss of dental 
cement, subcutaneous haemorrhage) 
  all-cause mortality  
B1 - Thiamine Co-enzyme in pyruvate and 2-keto-glutarate 
dehydrogenase and transketolase, Poorly defined role in 
nerve conduction 
 Beri beri (peripheral nerve damage), Wernicke–
Korsakoff–syndrome (central nerve damage) 
  
B2 - Riboflavine Co-enzyme in oxidation and reduction reactions, 
prosthetic group of flavoproteins 
 Lesions of corner of mouth, lips and tongue; 
seborrhoeic dermatitis 
  
Niacin - Nicotinic 
acid, Nicotinamide 
Co-enzyme in oxidation and reduction reactions, 
functional part of NAD and NADP 
 Pellagra (photosensitive dermatitis, depressive 
psychosis) 
  
B6 - Pyridoxine, 
Pyridoxal, 
Pyridoxamine 
Co-enzyme in transamination and decarboxylation of 
amino acids and glycogen phosphorylase, steroid hormone 
production 
 Disorders of amino acid metabolism, 
convulsions 
  
B9 - Folic acid Co-enzyme in transfer of one carbon fragments  Megaloblastic anaemia, neural tube defects in 
babies 
  Some cancers, especially 
colorectal cancer 
B12 - Cobalamin Co-enzyme in transfer of one carbon fragments and 
metabolism of folic acid 
 Pernicious anaemia (megaloblastic anaemia 
with degeneration of the spinal cord) 
  
Pantothenic acid Functional part of coenzyme A and acyl carrier protein  Neuromotor disorders, mental depression, GI 
complaints and increased insulin sensitivity 
  
Biotin Co-enzyme in carboxylation reactions in gluconeogenesis 
and fatty acid synthesis 
 Impaired fat and carbohydrate metabolism, 
dermatitis 
   
Minerals Physiological functions   Known deficiency diseases(a)  Possible benefits of high 
status(23, 24) 
Calcium Skeletal growth and development, vascular and muscle 
contraction, nerve transmission, insulin release 
 Failure to attain peak bone mass, osteoporosis 
in later life 
  Hypertension and colon 
cancer 
Chloride Hydrochloric acid in the stomach, chloride shift in 
erythrocyte plasma membrane, regulation of osmotic and 
electrolyte balances 
 Not diet related– only due to clinical conditions, 
eg: major trauma 
  
Chromium Insulin action, carbohydrate, lipid and nucleic acid 
metabolism 
 Severe deficiency can cause insulin resistance   
Copper Immune, nervous and cardiovascular systems, bone 
health, iron metabolism, haemoglobin synthesis, 
regulation of mitochondria, other gene expression.  
 Unlikely due to remarkable homeostatic 
mechanisms 
  (speculation) 
cardiovascular disease and 
osteoporosis 
Fluoride Fluorapatite in teeth and bones  Increased risk of dental caries   
Iodine Thyroid hormones  growth and mental development, 
possibly antibiotic and anti-cancer 
 Goitre, hypothyroidism, cretinism (collectively 
termed iodine deficiency disorders) 
 Infection control and 
cancer prevention 
Iron Oxygen transport and storage, catalytic centre for a broad 
spectrum of metabolic functions cell respiration and 
energy production, immune system, myelination and 
nerve development in fetus 
 Iron deficiency and iron deficiency anaemia, 
impairment of the immune response, adverse 
effect on psychomotor and mental development 
in children 
  
Magnesium Wide range of fundamental cellular reactions, >300 
enzymatic steps in metabolism, skeletal development, 
gene regulation, nerve and muscle cell conduction 
 Only in diseased states or due to a rare genetic 
abnormality 
  Cardiovascular disease, 
type II diabetes, 
hypertension, osteoporosis 
Manganese Catalytic co-factor for mitochondrial superoxide 
dismutase, arginase and pyruvate carboxylase 
 Rare - weight loss, dermatitis, growth 
retardation of hair and nails, decline of blood 
lipids 
  
Molybdenum Co-factor for the iron- and flavin-containing enzymes that 
catalyse hydroxylation 
 Deficiency difficult to induce   
Phosphorus Hydroxyapatite in calcified tissues, phospholipids in 
biological membranes, nucleotides and nucleic acid, 
maintenance of normal pH, storage and transfer of 
energy, activation of catalytic enzymes by 
phosphorylation 
 Hypophosphataemia resulting in cellular 
dysfunction – may include anorexia, anaemia, 
muscle weakness, bone pain, rickets and 
osteomalacia, general debility, increased 
infections, paraesthesia, ataxia, confusion 
  
Potassium Major intracellular electrolyte – regulation of osmotic 
pressure and electrolyte balance, normal functioning of 
cardiovascular, respiratory, digestive, renal and endocrine 
systems, energy metabolism, cell growth and division 
 Low potassium intakes unlikely to lead to 
clinical potassium depletion and hypokalaemia 
except during starvation and anorexia nervosa 
  Chronic heart failure and  
blood pressure 
Selenium Redox centre for the selenium-dependent glutathione 
peroxidases (antioxidant), thyroid hormone metabolism 
 Keshan's disease – a cardiomyopathy affecting 
children and women of child-bearing age 
  Cancer incidence 
(particularly prostate), 
inflammatory conditions 
(e.g. rheumatoid arthritis, 
ulcerative colitis, 
pancreatitis, asthma) 
Sodium Major extracellular electrolyte – regulation of osmotic and 
electrolyte balances, nerve conduction, muscle 
contraction, energy-dependent cell transport systems, 
formation of mineral apatite of bone. 
 Not diet related – only due to clinical 
conditions, including major trauma 
  
Sulphur Component of many proteins, energy metabolism as part 
of the  electron transport chain 
    
Zinc Catalytic, structural and regulatory roles, >100 
metalloenzymes involved in energy metabolism, DNA & 
RNA synthesis, protein synthesis, expression of multiple 
genes, protection of mucosal cells, functioning of immune 
and reproductive systems 
 Growth retardation, sexual and skeletal 
immaturity, neuropsychiatric disturbances, 
dermatitis, alopecia, diarrhoea, susceptibility to 
infection and loss of appetite 
 Growth and development 
in children,  risk of low 
birth weight and  pre-term 
delivery 
(a)
  Overt micronutrient deficiency diseases due to dietary insufficiency are rare, particularly in industrialised countries (more likely to be due to a clinical deficiency e.g. B12 
deficiency caused by failure of intrinsic factor secretion).Worldwide the most common dietary deficiencies are vitamin A, iron and iodine (25) 
 
  
Table 2| Main outcomes of the NDNS rolling survey 2008-2012 for micronutrients (7) 
 Females (age group) Males (age group) 
 4-10 11-18 19-64 65+ 4-10 11-18 19-64 65+ 
Dietary intake (% of population with daily intakes <LRNI)(a) 
Vitamin A  14    11   
Riboflavin  20 11   9   
Folate  7       
Vitamin D(b)         
Iron  45 21      
Calcium  19       
Magnesium(c)  52 11   28 16 19 
Potassium(c)  33 23 14  16 11 13 
Zinc(c) 11 22    11  10 
Selenium(c)  45 49 48  22 25 29 
Iodine  22 10      
Biochemical data (% of population with plasma levels <threshold) 
Vitamin D(d) 16 24 22 24 12 20 24 17 
Iron(e) 21 28 16  11    
(a)
  Population may be at risk of deficiency if a significance percentage has daily intakes below LRNI for a 
sustained period of time  
(b)
  Insufficient evidence to set LRNI for Vitamin D 
(c)  
Caution very limited data used to set DRVs 
(d)  
Plasma concentrations of 25-hydroxyvitamin D <25nmol/L (threshold below which there is an increased risk 
of rickets and osteomalacia)   
(e)
  Plasma concentrations of ferritin <15µg/L (threshold below which iron stores are considered to be 
depleted and the risk of iron-deficiency anaemia increased) 
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